Cargando…
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro
BACKGROUND: Osteosarcoma (OS) affects over 8000 dogs/year in the United States. The disease usually arises in the appendicular skeleton and metastasizes to the lung. Dogs with localized appendicular disease benefit from limb amputation and chemotherapy but most die within 6–12 months despite these t...
Autores principales: | Marley, Kevin, Helfand, Stuart C, Edris, Wade A, Mata, John E, Gitelman, Alix I, Medlock, Jan, Séguin, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551657/ https://www.ncbi.nlm.nih.gov/pubmed/23331343 http://dx.doi.org/10.1186/1746-6148-9-15 |
Ejemplares similares
-
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
por: Marley, Kevin, et al.
Publicado: (2013) -
Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs
por: Marley, Kevin, et al.
Publicado: (2015) -
Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line
por: Hodge, McKaela A., et al.
Publicado: (2023) -
Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro
por: Milovancev, Milan, et al.
Publicado: (2016) -
Comparison of Carboplatin and Doxorubicin‐Based Chemotherapy Protocols in 470 Dogs after Amputation for Treatment of Appendicular Osteosarcoma
por: Selmic, L.E., et al.
Publicado: (2014)